World Head and Neck Cancer Awareness Day 2025: The HPV Vaccine Could Save Your Life
27th July 2025
This World Head and Neck Cancer Awareness Day, Oracle Head and Neck Cancer UK has a simple but urgent message: HPV vaccination saves lives.
With HPV-related head and neck cancers having doubled in the past 20 years, the charity is using today to remind the public that these devastating cancers are preventable – but only if more people get vaccinated.
The Growing Threat
The most common type of head and neck cancer is oropharyngeal (throat) cancer, which is increasingly linked to HPV – the same virus that causes cervical cancer.
“HPV-related throat cancers are among the fastest-growing cancer types in the UK,” explained Tamara Kahn, CEO of Oracle Head and Neck Cancer UK. “While we’re winning the battle against cervical cancer through vaccination and screening, throat cancer – particularly in men – continues to rise at an alarming rate.”
The tragedy is that a vaccine exists that’s 99% effective against HPV-related cancers. Research shows it could prevent more than 100,000 cases of cancer in the UK by 2058 – yet uptake remains stubbornly low.
A Son’s Mission
University student Jake Hazari-Webb understands the stakes better than most. His father is living with stage 4 HPV-related head and neck cancer, and Jake has channelled his experience into action.
“Watching my dad go through this has been devastating, especially knowing it could have been prevented,” said Jake, who features in Oracle Head and Neck Cancer UK’s awareness video released today. “The vaccine is free, it’s safe, and it takes minutes. No family should have to go through what we’re going through.”
Earlier this year, Jake ran 70,000 metres (70km) in a single day – representing the 70,000 men diagnosed globally with HPV-related cancers annually. His efforts have sparked vital conversations about HPV vaccination among his peers at university.

“Most young people think HPV only causes cervical cancer,” Jake explained. “They don’t realise it’s a major cause of throat cancer too, especially in men. I’m determined to change that, one conversation at a time.”
Get Protected Now
It’s not too late to get protected. Free HPV vaccination is available through the NHS for:
- All secondary school children from age 12
- Girls under 25 (catch-up programme)
- Boys born after 1st September 2006 (catch-up programme)
- Those at higher risk (check NHS website for eligibility)
“If you missed the vaccine at school, you can still get it,” stressed Kahn. “Don’t wait until it’s too late. Book your vaccination today.”
Take Action Today
Oracle Head and Neck Cancer UK is urging everyone to play their part:
Watch and share Oracle’s HPV vaccination awareness video – every share (via email, social media, mobile) could help prevent future cancers
Sign the petition calling on the government to boost HPV vaccine uptake and protect future generations
Get involved – Our new events page launches next week, featuring activities for every fitness level to help you fundraise for life-saving work
- Runs, walks, treks and cycles
- The Mardi Himal Trek and other adventure challenges
- Community fundraising events
“Prevention is always better than cure,” concluded Kahn. “Together, we can ensure that future generations don’t have to face these devastating but preventable cancers.”
Cancer Care: Why Mental Health Support Must Be Part of Every Cancer Journey
Oracle Head & Neck Cancer UK is proud to support the Daily Express Cancer Care campaign, a powerful series that shines a light on the often unseen emotional toll of cancer – and the urgent need for better psychological support for everyone affected. The campaign published over the past three weeks featured voices from across…
Ground-breaking blood test shows promise for early detection of head & neck and other hard-to-screen cancers
A new large-scale trial has found that the blood-based screening test known as Galleri test can detect more than 50 types of cancer – including cancers of the head and neck, which currently have no routine screening programme – and may significantly boost early diagnosis. The trial showed that, when used alongside existing screening methods,…
2 Minutes to Save Your Life: Oracle Launches HeadNeckCheck Campaign for Make Sense Week
This Make Sense Week (15-20 September), the European-wide head and neck cancer awareness initiative, Oracle Head & Neck Cancer UK, is championing both prevention and early detection – recognising that stopping cancer before it starts is just as vital as catching it early. Two Ways to Fight Cancer This Week Prevention Today: Head and neck…
Leadership update
After four successful years as CEO, Tamara Kahn has transformed Oracle into a respected national voice for head and neck cancer patients. She established a national presence, created a four-pillar RACE strategy (Research, Awareness, Collaboration and Patient/Community Engagement) and built strong policy influence. With these foundations now firmly in place, Tamara will transition from her…
Finding Light in Adversity: Seven inspiring stories through head and neck cancer
A new collection of patient stories from Oracle Head and Neck Cancer UK reveals how individuals facing head and neck cancer have discovered unexpected sources of strength, purpose and even joy during their treatment and recovery. The seven contributors share remarkably similar themes despite their unique journeys. Almost all emphasise the power of maintaining a…
NHS to fast-track patients with head and neck cancer into cancer vaccine trial
Patients with advanced head and neck cancers in England will be fast-tracked into a trial of a new cancer vaccine, as the NHS expands its world-leading trial ‘match-making’ service. The investigational cancer vaccine uses mRNA technology to help the immune system recognise and kill cancer cells containing human papillomavirus proteins. More than 100 patients with advanced head…
Data from the National Disease Registration Service on HPV associated and HPV independent oropharyngeal squamous cell carcinoma
The Get Data Out Programme from the National Disease Registration Service (NDRS), part of NHS England, has published statistics on incidence, routes to diagnosis and treatment for patients diagnosed with oropharyngeal cancer in England by human papillomavirus (HPV) status. To our knowledge this is the first time data on oropharyngeal cancer by HPV status has…
Join Us for an Evening of Research, Impact, and Conversation
Research & Impact EveningDate: Monday 28th April 2025Time: 6:00 PM – 8:30 PMVenue: Skyline, Tower Suites, 100 Minories, London EC3N 1JY A Celebration of Research Join us for a meaningful and action-focused evening where we’ll be diving into some of the big conversations around head and neck cancer – especially those linked to HPV (human…
What the Rare Cancers Bill Means for Head & Neck Cancer
14 March marked a crucial moment for research into rare cancers, as the Rare Cancers Bill took another significant step toward becoming law! Dr. Scott Arthur, a Labour MP, introduced this legislation in Parliament to drive much-needed research into cancers affecting fewer than 1 in 2000 people in the UK – including many types of…
Theatre Meets Healthcare: Breaking Barriers in Cancer Conversations
In Leicester, theatre is transforming how Black communities talk about cancer. Oracle Head & Neck Cancer UK, alongside Theatre Sans Frontières, is using interactive Forum Theatre to tackle stigma, improve healthcare conversations, and break down cultural barriers. Actors bring real-life cancer diagnosis experiences to the stage – but the audience isn’t just watching. They step in, suggest changes, and…